One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
doi: https://doi.org/10.1101/2021.10.16.21265095
Otavio T Ranzani
1Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain
2Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Brazil
Amanda A B Silva
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Igor T Peres
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Bianca B P Antunes
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Thiago W Gonzaga-da-Silva
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
Daniel R Soranz
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
5Public Health National School, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
José Cerbino-Neto
4Rio de Janeiro Municipal Health Department, Rio de Janeiro, Brazil
6National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
Silvio Hamacher
3Department of Industrial Engineering (DEI) and Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil
Fernando A Bozza
6National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil
7D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted October 20, 2021.
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
medRxiv 2021.10.16.21265095; doi: https://doi.org/10.1101/2021.10.16.21265095
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Otavio T Ranzani, Amanda A B Silva, Igor T Peres, Bianca B P Antunes, Thiago W Gonzaga-da-Silva, Daniel R Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A Bozza
medRxiv 2021.10.16.21265095; doi: https://doi.org/10.1101/2021.10.16.21265095
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2666)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12278)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2677)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3920)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (591)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1121)
- Primary Care Research (458)
- Public and Global Health (6556)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)